UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psilocybin: Good Trip or Bad Trip

Clinical pharmacology and therapeutics, 2017-10, Vol.102 (4), p.580-584

Sellers, EM

2017

Volltextzugriff (PDF)

Deconstructing Designer Drugs

Clinical pharmacology and therapeutics, 2017-02, Vol.101 (2), p.167-169

Sellers, EM

2017

Volltextzugriff (PDF)

Resistivity Saturation in Metallic Liquids Above a Dynamical Crossover Temperature Observed in Measurements Aboard the International Space Station

Physical review letters, 2019-11, Vol.123 (22), p.226601-226601, Article 226601

2019

Volltextzugriff (PDF)

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting

Clinical pharmacology and therapeutics, 2016-09, Vol.100 (3), p.275-286

2016

Volltextzugriff (PDF)

Measurement issues in postpartum depression part 1: Anxiety as a feature of postpartum depression

Archives of women's mental health, 2003-02, Vol.6 (1), p.51-57

2003

Volltextzugriff (PDF)

Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT ) Receptor Agonist, in Recreational Polydrug Users

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.683-692

2011

Volltextzugriff (PDF)

Update on tamper-resistant drug formulations

Drug and alcohol dependence, 2013-06, Vol.130 (1), p.13-23

2013

Volltextzugriff (PDF)

Assessing Abuse Liability During Drug Development: Changing Standards and Expectations

Clinical pharmacology and therapeutics, 2008-04, Vol.83 (4), p.622-626

2008

Volltextzugriff (PDF)

A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes

The Journal of pharmacology and experimental therapeutics, 1997-09, Vol.282 (3), p.1608

1997

Volltextzugriff (PDF)

Mood changes during pregnancy and the postpartum period: development of a biopsychosocial model

Acta psychiatrica Scandinavica, 2004-06, Vol.109 (6), p.457-466

2004

Volltextzugriff (PDF)

Demonstration of the effect of stirring on nucleation from experiments on the International Space Station using the ISS-EML facility

NPJ microgravity, 2021-08, Vol.7 (1), p.31-31, Article 31

2021

Volltextzugriff (PDF)

Oral ketamine as a positive control in human abuse potential studies

Drug and alcohol dependence, 2011-04, Vol.114 (2), p.185-193

2011

Volltextzugriff (PDF)

Nicotine metabolism defect reduces smoking

Nature (London), 1998-06, Vol.393 (6687), p.750-750

1998

Volltextzugriff (PDF)

Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users

Clinical pharmacology and therapeutics, 2010-07, Vol.88 (1), p.69-78

2010

Volltextzugriff (PDF)

Human dopamine transporter gene : coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations

Molecular psychiatry, 2000-05, Vol.5 (3), p.283-292

2000

Volltextzugriff (PDF)

Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk

Drug metabolism and disposition, 2001-04, Vol.29 (4 Pt 2), p.548

2001

Volltextzugriff (PDF)

An in Vivo Pilot Study Characterizing the New CYP2A67, 8, and 10 Alleles

Biochemical and biophysical research communications, 2002-01, Vol.290 (1), p.318-324

2002

Volltextzugriff (PDF)

Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

Clinical pharmacology and therapeutics, 2000-07, Vol.68 (1), p.35-43

2000

Volltextzugriff (PDF)

Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice

The Journal of pharmacology and experimental therapeutics, 2007-01, Vol.320 (1), p.250-257

2007

Volltextzugriff (PDF)

Venlafaxine oxidation in vitro is catalysed by CYP2D6

British journal of clinical pharmacology, 1996-02, Vol.41 (2), p.149-156

1996

Volltextzugriff (PDF)

Maximum supercooling studies in Ti39.5Zr39.5Ni21, Ti40Zr30Ni30, and Zr80Pt20 liquids—Connecting liquid structure and the nucleation barrier

The Journal of chemical physics, 2019-05, Vol.150 (20), p.204510-204510

2019

Volltextzugriff (PDF)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist

The Journal of pharmacology and experimental therapeutics, 2016-12, Vol.359 (3), p.471-481

2016

Volltextzugriff (PDF)

Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence

Canadian Medical Association journal, 2001-03, Vol.164 (6), p.817

2001

Volltextzugriff (PDF)

Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

Clinical pharmacology and therapeutics, 2008-04, Vol.83 (4), p.607-614

2008

Volltextzugriff (PDF)

Characteristics of dependent and nondependent regular users of codeine

Journal of clinical psychopharmacology, 1999-08, Vol.19 (4), p.367-372

1999

Volltextzugriff (PDF)

1 – 25 von 1.466

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.266)
Mit Volltextzugriff
(1.066)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Psilocybin: Good Trip or Bad Trip

Deconstructing Designer Drugs

Resistivity Saturation in Metallic Liquids Above a Dynamical Crossover Temperature Observed in Measurements Aboard the International Space Station

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting

Measurement issues in postpartum depression part 1: Anxiety as a feature of postpartum depression

Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT ) Receptor Agonist, in Recreational Polydrug Users

Update on tamper-resistant drug formulations

Assessing Abuse Liability During Drug Development: Changing Standards and Expectations

A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes

Mood changes during pregnancy and the postpartum period: development of a biopsychosocial model

Demonstration of the effect of stirring on nucleation from experiments on the International Space Station using the ISS-EML facility

Oral ketamine as a positive control in human abuse potential studies

Nicotine metabolism defect reduces smoking

Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users

Human dopamine transporter gene : coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations

Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk

An in Vivo Pilot Study Characterizing the New CYP2A67, 8, and 10 Alleles

Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice

Venlafaxine oxidation in vitro is catalysed by CYP2D6

Maximum supercooling studies in Ti39.5Zr39.5Ni21, Ti40Zr30Ni30, and Zr80Pt20 liquids—Connecting liquid structure and the nucleation barrier

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist

Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence

Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

Characteristics of dependent and nondependent regular users of codeine

Suchergebnisse filtern